Literature DB >> 21671469

The cancer burden in the United Kingdom in 2007 due to radiotherapy.

Jacob Maddams1, D Maxwell Parkin, Sarah C Darby.   

Abstract

The number of long-term cancer survivors in the general population of the UK is substantial and increasing rapidly. Many cancer survivors have been treated with radiotherapy but the likely number of radiotherapy-related second cancers has not previously been estimated. We used estimates of the numbers of cancer survivors in the UK at the beginning of 2007, in conjunction with estimates of the relative risk of a second primary cancer associated with previous radiotherapy from the United States Surveillance Epidemiology and End Results (SEER) programme, to estimate the numbers of incident cancers in the UK in 2007 that were associated with radiotherapy for a previous cancer and that may have been caused by it. We estimated that 1,346 cases of cancer, or about 0.45% of the 298,000 new cancers registered in the UK in 2007, were associated with radiotherapy for a previous cancer. The largest numbers of radiotherapy-related second cancers were lung cancer (23.7% of the total), oesophageal cancer (13.3%), and female breast cancer (10.6%); 54% of radiotherapy-related second cancers were in individuals aged 75 or over. The highest percentages of second cancers related to radiotherapy were among survivors of Hodgkin's disease and cancers of the oral cavity and pharynx and cervix uteri; over 15% of second cancers among these survivors were associated with radiotherapy for the first cancer. These calculations, which involve a number of assumptions and approximations, provide a reasonable, if conservative, estimate of the fraction of incident cancers in the UK that are attributable to past radiation therapy.
Copyright © 2011 UICC.

Entities:  

Mesh:

Year:  2011        PMID: 21671469     DOI: 10.1002/ijc.26240

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Densely ionizing radiation affects DNA methylation of selective LINE-1 elements.

Authors:  Sara Prior; Isabelle R Miousse; Etienne Nzabarushimana; Rupak Pathak; Charles Skinner; Kristy R Kutanzi; Antiño R Allen; Jacob Raber; Alan J Tackett; Martin Hauer-Jensen; Gregory A Nelson; Igor Koturbash
Journal:  Environ Res       Date:  2016-07-14       Impact factor: 6.498

2.  Risk of treatment-related esophageal cancer among breast cancer survivors.

Authors:  L M Morton; E S Gilbert; P Hall; M Andersson; H Joensuu; L Vaalavirta; G M Dores; M Stovall; E J Holowaty; C F Lynch; R E Curtis; S A Smith; R A Kleinerman; M Kaijser; H H Storm; E Pukkala; R E Weathers; M S Linet; P Rajaraman; J F Fraumeni; L M Brown; F E van Leeuwen; S D Fossa; T B Johannesen; F Langmark; S Lamart; L B Travis; B M P Aleman
Journal:  Ann Oncol       Date:  2012-06-27       Impact factor: 32.976

3.  Mutations of the human interferon alpha-2b (hIFNα-2b) gene in cancer patients receiving radiotherapy.

Authors:  Saman Shahid; Muhammad Nawaz Chaudhry; Nasir Mahmood
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

4.  Endonuclease G initiates DNA rearrangements at the MLL breakpoint cluster upon replication stress.

Authors:  B Gole; C Baumann; E Mian; C I Ireno; L Wiesmüller
Journal:  Oncogene       Date:  2014-08-18       Impact factor: 9.867

5.  Risk of subsequent cancer following a primary CNS tumor.

Authors:  Kyle Strodtbeck; Andrew Sloan; Lisa Rogers; Paul Graham Fisher; Duncan Stearns; Laura Campbell; Jill Barnholtz-Sloan
Journal:  J Neurooncol       Date:  2013-02-08       Impact factor: 4.130

6.  Combined exposure to protons and (56)Fe leads to overexpression of Il13 and reactivation of repetitive elements in the mouse lung.

Authors:  Etienne Nzabarushimana; Sara Prior; Isabelle R Miousse; Rupak Pathak; Antiño R Allen; John Latendresse; Reid H J Olsen; Jacob Raber; Martin Hauer-Jensen; Gregory A Nelson; Igor Koturbash
Journal:  Life Sci Space Res (Amst)       Date:  2015-08-18

7.  An novel role of sphingosine kinase-1 (SPHK1) in the invasion and metastasis of esophageal carcinoma.

Authors:  Jian Pan; Yan-Fang Tao; Zhuan Zhou; Bang-Rong Cao; Shui-Yan Wu; Yan-Lan Zhang; Shao-Yan Hu; Wen-Li Zhao; Jian Wang; Guo-Liang Lou; Zhen Li; Xing Feng; Jian Ni
Journal:  J Transl Med       Date:  2011-09-22       Impact factor: 5.531

8.  12. Cancers in 2010 attributable to ionising radiation exposure in the UK.

Authors:  D M Parkin; S C Darby
Journal:  Br J Cancer       Date:  2011-12-06       Impact factor: 7.640

9.  Radiation-associated Angiosarcoma Presenting as Massive Pleural Effusion.

Authors:  Hirokazu Ogino; Makoto Tobiume; Kozo Kagawa; Hiroshi Kawano; Satoshi Sakaguchi; Atsuro Saijo; Daisuke Matsumoto; Hiromitsu Takizawa; Yuriko Morikawa; Yoshimi Bando; Hisatsugu Goto; Hiroshi Nokihara; Yasuhiko Nishioka
Journal:  Intern Med       Date:  2021-10-12       Impact factor: 1.282

Review 10.  Leukemogenic rearrangements at the mixed lineage leukemia gene (MLL)-multiple rather than a single mechanism.

Authors:  Boris Gole; Lisa Wiesmüller
Journal:  Front Cell Dev Biol       Date:  2015-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.